New heart mapping technology aims to better target irregular heartbeat sources
NCT ID NCT06960252
Summary
This study is testing whether a new high-density mapping catheter called OPTRELL can better identify the specific areas in the heart that cause persistent atrial fibrillation (AF). Researchers will use this mapping to guide radiofrequency ablation, a procedure that creates small scars to block abnormal electrical signals. The goal is to see if this targeted approach reduces the recurrence of irregular heart rhythms compared to standard ablation techniques.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taipei Veterans General Hospital
RECRUITINGTaipei, Outside US, 112, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.